Metraipolis › archive › dc_504fcdc784b0

Artificial Intelligence Across the Drug Development Lifecycle — Europe PMC PMID:42201040

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42201040
DOI
10.3390/medsci14020248
License (as archived)
solo-consultazione
Archived
2026-10-07T11:29:53.499Z
SHA-256 of the archived text
8c6dee4568eaf73ef37d6ddda77b5f2aef54a31def59c5293eb596db14427caf
Stable URL of this page
https://metraipolis.com/documento/dc_504fcdc784b0

How to cite

Artificial Intelligence Across the Drug Development Lifecycle — Europe PMC PMID:42201040 — Europe PMC (en), https://europepmc.org/article/MED/42201040 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_504fcdc784b0 (Metraipolis archive dc_504fcdc784b0, sha256 8c6dee4568eaf73ef37d6ddda77b5f2aef54a31def59c5293eb596db14427caf)
BibTeX
@misc{dc504fcdc784b0,
  title = {Artificial Intelligence Across the Drug Development Lifecycle — Europe PMC PMID:42201040},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42201040},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_504fcdc784b0; sha256 8c6dee4568eaf73ef37d6ddda77b5f2aef54a31def59c5293eb596db14427caf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42201040. Agents can read the archived copy with the MCP tool read_document.